Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 26/08/19971 min de lecture
Implantation or Injectable Dosage Form New Animal Drugs; Polysulfated Glycosaminoglycan
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Luitpold Pharmaceuticals, Inc. The NADA provides for intramuscular injection of polysulfated glycosaminoglycan for dogs for control of signs associated with noninfectious degenerative and/or traumatic arthritis of canine synovial joints.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →